Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05115305 · ClinicalTrials.gov registry record
Prodigy, a Level 2 Sleep Study Device, Validation Study
A clinical trial of Sleep Apnea, sponsored by Cerebra Medical.
- Completed
- Registry status
- 84
- Enrollment target
- 2
- Study locations
NCT05115305 is a study of Sleep Apnea that has completed, run by Cerebra Medical. The registered enrollment target is 84 participants, below the 2,987-participant average among 36 other Sleep Apnea trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05115305, a study of Sleep Apnea, has completed, sponsored by Cerebra Medical.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same information in the home that is currently only obtained in in-laboratory studies. The objective of the current study is to demonstrate that the signals obtained by this comprehensive, portable system are comparable to those obtained in in-laboratory studies.
Conditions Studied
Study Locations (2)
New York
- St Charles Sleep Disorders Center - Port Jefferson
Ontario
- Hamilton Sleep Disorders Clinic - Hamilton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2022-04-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05115305
The ClinicalTrials.gov registry entry for NCT05115305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,987-participant average among 36 other Sleep Apnea trials with a reported enrollment target (97% lower). The listed sponsor is Cerebra Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT05115305 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Ontario.
Frequently Asked Questions
What is clinical trial NCT05115305 about?
NCT05115305 is a clinical study titled "Prodigy, a Level 2 Sleep Study Device, Validation Study". The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same information in the home that is currently only obtained in in-laboratory studies. The objective of the current study is to demonstrate that the signals obtained by this comprehensive, portable system are com...
What is the current status of trial NCT05115305?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2022-01-14. Estimated completion is 2022-04-09.
What conditions does trial NCT05115305 study?
This clinical trial studies the following conditions: Sleep Apnea.
Who is sponsoring clinical trial NCT05115305?
This trial is sponsored by Cerebra Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05115305 being conducted?
This trial has 2 study locations across New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Research Framework Exploring Sleep Health
RECRUITING
-
Mechanisms of Prediabetic States in Sleep Apnea
RECRUITING · NA
-
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
RECRUITING · Phase 4
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Sleep Apnea in Elderly
RECRUITING · Phase 4
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.